TATTOO-Study

Tattooing suspicious axillary lymph nodes in breast cancer patients treated by primary systemic therapy
Below please find

Tattooing suspicious axillary lymph nodes in breast cancer patients treated by primary systemic therapy

  • PI: Steffi Hartmann (MD)
  • study initiated by EUBREAST
  • Kind of trial: prospective feasibility trial
  • Primary study endpoint: Detection rate of charcoal tattooed axillary lymph nodes during surgery after primary systemic therapy in breast cancer patients.
  • Publication Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial
Become a member to stay updated!
The Benefits of EUBREAST Membership
Enter into a network of renowned international breast surgeons
Access to detailed information on ongoing and previous projects and events
Take part in international cross-border studies
Publish your EUBREAST membership status on your website / social media platforms together with the respective logo.